These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15324602)

  • 1. Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment.
    Mulnard RA; Corrada MM; Kawas CH
    Curr Neurol Neurosci Rep; 2004 Sep; 4(5):368-73. PubMed ID: 15324602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What we know about estrogen's effect on the brain.
    Mitchell JL
    Curr Womens Health Rep; 2002 Oct; 2(5):382-9. PubMed ID: 12215311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can estrogen play a significant role in the prevention of Alzheimer's disease?
    Kesslak JP
    J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can estrogens prevent neurodegeneration?
    Schneider LS; Finch CE
    Drugs Aging; 1997 Aug; 11(2):87-95. PubMed ID: 9259172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
    Henderson VW; Paganini-Hill A; Emanuel CK; Dunn ME; Buckwalter JG
    Arch Neurol; 1994 Sep; 51(9):896-900. PubMed ID: 8080389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy for cognitive benefits: viable treatment or forgettable "senior moment"?
    Marks SJ; Batra RR; Frishman WH
    Heart Dis; 2002; 4(1):26-32. PubMed ID: 11975829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.
    Maki PM
    Menopause; 2013 Jun; 20(6):695-709. PubMed ID: 23715379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and cognitive aging in women.
    Sherwin BB
    Trends Pharmacol Sci; 2002 Nov; 23(11):527-34. PubMed ID: 12413808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal treatment, mild cognitive impairment and Alzheimer's disease.
    Ryan J; Scali J; Carriere I; Ritchie K; Ancelin ML
    Int Psychogeriatr; 2008 Feb; 20(1):47-56. PubMed ID: 18072983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease.
    Miller MM; Monjan AA; Buckholtz NS
    Ann N Y Acad Sci; 2001 Dec; 949():223-34. PubMed ID: 11795357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
    Mulnard RA; Cotman CW; Kawas C; van Dyck CH; Sano M; Doody R; Koss E; Pfeiffer E; Jin S; Gamst A; Grundman M; Thomas R; Thal LJ
    JAMA; 2000 Feb; 283(8):1007-15. PubMed ID: 10697060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and Alzheimer's disease: the story so far.
    Cholerton B; Gleason CE; Baker LD; Asthana S
    Drugs Aging; 2002; 19(6):405-27. PubMed ID: 12149049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens and brain function.
    Markou A; Duka T; Prelevic GM
    Hormones (Athens); 2005; 4(1):9-17. PubMed ID: 16574627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial.
    Henderson VW; Paganini-Hill A; Miller BL; Elble RJ; Reyes PF; Shoupe D; McCleary CA; Klein RA; Hake AM; Farlow MR
    Neurology; 2000 Jan; 54(2):295-301. PubMed ID: 10668686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.